Data / Federal rules / 2026-11526
Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
The Drug Enforcement Administration published this final rule in the Federal Register on June 9, 2026. It took effect on July 9, 2026.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
The "Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act)," which became law on October 24, 2018, amended the Controlled Substances Act to expand the conditions a practitioner must meet to provide medication-assisted treatment for opioid use disorder and expand the options available for a physician to be considered a qualifying physician. The SUPPORT Act also allowed a pharmacy to deliver prescribed controlled substances to a practitioner's registered location for the purpose of maintenance or detoxification treatment to be administered under certain conditions by a practitioner. The Drug Enforcement Administration promulgated an interim final rule with request for comments in November 2020 to amend its regulations to make them consistent with the SUPPORT Act and implement its requirements. On December 29, 2022, the Restoring Hope for Mental Health and Well-Being Act of 2022 removed many of the statutory provisions of the SUPPORT Act. This final rule adopts the provisions of the interim final rule that are still applicable as final, with minor changes. In addition, this final rule implements the related provisions of the Restoring Hope for Mental Health and Well-Being Act of 2022.
Key facts
- Document number
- 2026-11526
- Type
- Final rule
- Action
- Final rule
- Agency
- Justice Department; Drug Enforcement Administration
- Published
- June 9, 2026
- Takes effect
- July 9, 2026
- Dates
- This final rule is effective July 9, 2026.
- Docket
- Docket No. DEA-499
- Regulation ID (RIN)
- 1117-AB55
- Code of Federal Regulations
- 21 CFR 1300; 21 CFR 1301; 21 CFR 1306
- Topics
- Administrative practice and procedure; Chemicals; Drug traffic control; Prescription drugs; Security measures
- Significant
- Yes, under Executive Order 12866
- Pages
- 15
Other documents from the Drug Enforcement Administration
Everything from the Drug Enforcement Administration · Rules on administrative practice and procedure · Rules on chemicals · Rules on drug traffic control · Published in June 2026
Read from the Federal Register API, last updated 2026-10-24. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.